Search

Gerard H Llanos

from Dundee, NY
Age ~49
Get Report
Related to:
Paul D Llanos, 65Douglas Llanos, 100Helen Mary Llanos, 60Amelia R LlanosKaren L Llanos, 61Gerald R LlanosDonald J LlanosJanice M LlanosG Llanos, 64
Connected to:
Adolfo R Llanos, 60Angela M Llanos, 39Armando E Llanos, 75Carmelo Llanos, 88Cesar W Llanos, 65Cheryl A Llanos, 65Christina Llanos, 37Cinthia M Llanos, 34David J Llanos, 90Ella M Llanos, 50

Gerard Llanos Phones & Addresses

  • Dundee, NY
  • Stewartsville, NJ
  • 201 Berkley Rd, Hollywood, FL 33024 (954) 985-2594

Work

Company: Generative leadership group, l.l.c. Address: 50 Division St Ste 202, Millstone, NJ 08876 Phones: (908) 722-5100 Position: Research fellow Industries: Management Consulting Services

Business Records

Name / Title
Company / Classification
Phones & Addresses
Gerard Llanos
Research Fellow
Generative Leadership Group, L.L.C.
Management Consulting Services
50 Division St Ste 202, Millstone, NJ 08876
Gerard Llanos
Research Fellow
Generative Leadership Group, L.L.C.
Management Consulting Services
50 Division St Ste 202, Millstone, NJ 08876
Gerard Llanos
Research Fellow
Generative Leadership Group LLC
Management Consulting · Management Consulting Services · Business Management Consultant · Process & Logistics Consulting Svcs
92 E Main St SUITE 205, Somerville, NJ 08876
50 Division St, Millstone, NJ 08876
PO Box 996, Millstone, NJ 08876
(908) 722-5100, (908) 393-6968, (908) 722-5103

Publications

Us Patents

Stent With Therapeutically Active Dosage Of Rapamycin Coated Thereon

View page
US Patent:
6585764, Jul 1, 2003
Filed:
Jun 4, 2001
Appl. No.:
09/874117
Inventors:
Carol Wright - Somerset NJ
Gerard H. Llanos - Stewartsville NJ
Ronald Rakos - Middlesex County NJ
Kristen King - Hoboken NJ
Assignee:
Cordis Corporation - Miami Lakes FL
International Classification:
A61F 206
US Classification:
623 142
Abstract:
Delivery of rapamycin locally, particularly from intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.

Device And Process For Coating Stents

View page
US Patent:
6723373, Apr 20, 2004
Filed:
Jun 16, 2000
Appl. No.:
09/595876
Inventors:
Pallassana Narayanan - Belle Mead NJ
Gerard H. Llanos - Stewartsville NJ
David Cook - Oakville, CA
Jacob Leidner - Toronto, CA
Assignee:
Cordis Corporation - Miami Lakes FL
International Classification:
B05D 300
US Classification:
427 225, 427 224, 623 146
Abstract:
A stent is positioned on an undersized mandrel and the stent is coated with an excess of a polymer and drug solution. The stent is rotated to spin off the excess of the coating. The stent is then moved into a new, clean position on the mandrel. The process is repeated a few times, after which time the coating is already dry and non-sticky. This process forms a conforming coating. Various important polymer solution parameters include viscosity, solvent evaporation rate and several others. The actual type of coating polymer is not as important as how the surface of the stent is treated, according to the steps described herein.

Coatings For Medical Devices

View page
US Patent:
6746773, Jun 8, 2004
Filed:
Sep 25, 2001
Appl. No.:
09/962292
Inventors:
Gerard H. Llanos - Stewartsville NJ
Pallassana Narayanan - Belle Mead NJ
Mark B. Roller - North Brunswick NJ
Angelo Scopelianos - Whitehouse Station NJ
Assignee:
Ethicon, Inc. - Somerville NJ
International Classification:
B23B 2700
US Classification:
428421, 6048901, 6048911, 604265, 623 142, 623 143, 623 144, 623 149
Abstract:
The present invention includes biocompatible coatings and films for use on implantable medical devices and medical devices containing such coatings and films applied to a surface thereof, which coatings/films are present on the device in an amount effective to provide an inert surface to be in contact with body tissue of a mammal upon implantation of the device in the mammal, and contain a film-forming polyfluoro copolymer containing the polymerized residue of a moiety selected from the group consisting of vinylidenefluoride and tetrafluoroethylene copolymerized with a second moiety other than the first moiety, wherein the relative amounts of the polymerized residue of the first and second moieties are effective to provide the coating and films with properties effective for use in coating implantable med devices.

Antiinflammatory Drug And Delivery Device

View page
US Patent:
6776796, Aug 17, 2004
Filed:
May 7, 2001
Appl. No.:
09/850232
Inventors:
Robert Falotico - Belle Mead NJ
Gregory A. Kopia - Neshanic NJ
Gerard H. Llanos - Stewartsville NJ
John Siekierka - Towaco NJ
Andrew J. Carter - Portland OR
Assignee:
Cordis Corportation - Miami Lakes FL
International Classification:
A61F 206
US Classification:
623 146
Abstract:
A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.

Stent Containing Rapamycin Or Its Analogs Using A Modified Stent

View page
US Patent:
6808536, Oct 26, 2004
Filed:
Apr 7, 2003
Appl. No.:
10/408328
Inventors:
Carol Wright - Somerset NJ, 08873
Gerard H. Llanos - Stewartsville NJ, 08886
Ronald Rakos - Monmouth Jct NJ
Kristen King - Hoboken NJ, 07030
International Classification:
A61F 206
US Classification:
623 142
Abstract:
Delivery of rapamycin locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.

Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon

View page
US Patent:
7056550, Jun 6, 2006
Filed:
Aug 7, 2003
Appl. No.:
10/636435
Inventors:
Luis A. Davila - Coral Springs FL, US
David Christian Lentz - Weston FL, US
Gerard H. Llanos - Stewartsville NJ, US
Jorge Orlando Mendez - Miami FL, US
Pallassana V. Narayanan - Belle Mead NJ, US
Alan Roy Pelton - Fremont CA, US
Mark B. Roller - North Brunswick NJ, US
Karl K. Scheidt - Pembroke Pines FL, US
Angelo George Scopelianos - Whitehouse Station NJ, US
James H. Silver - Palo Alto CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Union City CA, US
David J. Wilson - Branchburg NJ, US
Assignee:
Ethicon, Inc. - USA - Somerville NJ
International Classification:
B05D 1/36
B05D 3/02
US Classification:
427 224, 4274071
Abstract:
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.

Local Delivery Of Rapamycin For Treatment Of Proliferative Sequelae Associated With Ptca Procedures, Including Delivery Using A Modified Stent

View page
US Patent:
7217286, May 15, 2007
Filed:
Aug 24, 2006
Appl. No.:
11/467035
Inventors:
Robert Falotico - Bell Mead NJ, US
Gerard H. Llanos - Stewartsville NJ, US
Assignee:
Cordis Corporation - Miami Lakes FL
International Classification:
A61F 2/06
US Classification:
623 142
Abstract:
Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis.

Local Delivery Of Rapamycin For Treatment Of Proliferative Sequelae Associated With Ptca Procedures, Including Delivery Using A Modified Stent

View page
US Patent:
7223286, May 29, 2007
Filed:
Sep 28, 2004
Appl. No.:
10/951385
Inventors:
Carol Wright - Somerset NJ, US
Gerard H. Llanos - Stewartsville NJ, US
Ronald Rakos - Neshanic Station NJ, US
Kristin King - Mahwah NJ, US
Robert Falotico - Bell Mead NJ, US
Assignee:
Cordis Corporation - Miami Lakes FL
International Classification:
A61F 2/06
US Classification:
623 142
Abstract:
Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis.
Control profile
Gerard H Llanos from Dundee, NY, age ~49 Get Report